A Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protection.
<h4>Background</h4>The E7 protein of the Human Papillomavirus (HPV) type 16, being involved in malignant cellular transformation, represents a key antigen for developing therapeutic vaccines against HPV-related lesions and cancers. Recombinant production of this vaccine antigen in an act...
Enregistré dans:
Auteurs principaux: | Olivia C Demurtas, Silvia Massa, Paola Ferrante, Aldo Venuti, Rosella Franconi, Giovanni Giuliano |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/0963fa34853949e3bb62bab97b1d3536 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Maturation of the Human Papillomavirus 16 Capsid
par: Giovanni Cardone, et autres
Publié: (2014) -
Human papillomavirus in skin tags: a case series
par: Caterina Dianzani, et autres
Publié: (2018) -
Engineering the chloroplast targeted malarial vaccine antigens in Chlamydomonas starch granules.
par: David Dauvillée, et autres
Publié: (2010) -
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody
par: Shiwen Peng, et autres
Publié: (2021) -
Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription
par: Claire D. James, et autres
Publié: (2020)